// App-Quantinova.ai

1253 : Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage

Researchers

Presenter

  • Mariana Bego

Principal Investigators

  • Evan Colletti

  • Christopher D Porada

  • Esmail Zanjani

  • Stephen St. Jeor

  • Graca Almeida-Porada

Medical Centers

  • Wake Forest Institute for Regenerative Medicine, Winston Salem, NC.

  • Laboratory of Human Retrovirology, Institut de recherches cliniques de Montreal IRCM, Montreal, QC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 55

  • Cluster of differentiation 59

  • Mesenchymal stem cells

Drug/Treatment

  • folitixorin calcium

  • Canerpaturev

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved